Publication: An Uninformative Truth: The Logic of Amarin’s Off-Label Promotion
Open/View Files
Date
2016
Published Version
Journal Title
Journal ISSN
Volume Title
Publisher
Public Library of Science
The Harvard community has made this article openly available. Please share how this access benefits you.
Citation
Hey, Spencer Phillips, and Aaron S. Kesselheim. 2016. “An Uninformative Truth: The Logic of Amarin’s Off-Label Promotion.” PLoS Medicine 13 (3): e1001978. doi:10.1371/journal.pmed.1001978. http://dx.doi.org/10.1371/journal.pmed.1001978.
Research Data
Abstract
Spencer Phillips Hey and Aaron Kesselheim propose that informativeness—asserting scientific facts—rather than truthfulness ought to be the standard for regulating commercial speech about pharmaceuticals.
Description
Other Available Sources
Keywords
Medicine and Health Sciences, Pharmacology, Drugs, Statins, Health Care, Health Care Providers, Medical Doctors, Physicians, People and Places, Population Groupings, Professions, Biology and Life Sciences, Biochemistry, Lipids, Neuroscience, Cognitive Science, Cognitive Psychology, Reasoning, Psychology, Social Sciences, Fatty Acids, Drug Research and Development, Drug Marketing, Sociology, Marketing, Drug Regulation
Terms of Use
This article is made available under the terms and conditions applicable to Other Posted Material (LAA), as set forth at Terms of Service